EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Who Should Decide the Outcome for a Clinical Trial? Comparing the Views of Stakeholders on Intervention Benefit Using Multi-Criteria Decision Modelling of Cognitive Remediation

Xiaoyu Zhang iD, Til Wykes iD, Huajie Jin iD, Dominic Stringer iD, Andrew Pickles, Matteo Cella iD, Alex Kenny iD, Emese Csipke, Imogen Kilcoyne iD, Jesus Perez, Uzma Zahid iD, Jonathan Wilson iD und 4 weitere

Schizophrenia Bulletin · 10.04.2026 · 52 (3)

DOI: 10.1093/schbul/sbag006 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Schizophrenia Bulletin, online erschienen am 21.04.2026. Verfasst von Xiaoyu Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: King's College London, Institute of Psychiatry, Psychology and Neuroscience, Health Service and Population Research, London, SE5 8AF, UK. Hauptthemen laut MEDLINE: Cognitive Remediation, Decision Support Techniques, Outcome Assessment, Health Care, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, NIHR Maudsley Biomedical Research Centre, NIHR or the Department of Health and Social Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Trials rarely include outcomes co-developed with stakeholders, which creates uncertainty about whether trial endpoints reflect the benefits valued by patients and clinicians. There is therefore a need to explore how stakeholder perspectives might influence the interpretation of trial results. Study Design In a 2-phase study, we first engaged service users and staff to rank outcomes from a recently completed randomized controlled trial of cognitive remediation therapy (CRT). We then used multi-criteria decision modelling to generate value-weighted composite scores and reanalyzed the trial data from three arms: individual CRT, group CRT, and treatment as usual (TAU). This approach allowed us to examine how weighting outcomes differently, according to stakeholder perspectives, might affect the conclusions drawn from the trial. Study Results Both stakeholder groups prioritized the Global Assessment Scale (primary outcome) and quality of life, but disagreed on the importance of cognition. Reanalyses using weighted composite scores produced the same robust finding as the original trial: CRT delivered in group or one-to-one formats provides significant benefit compared with TAU. Sensitivity analyses applying different stakeholder weights showed the same pattern. However, exploratory analyses revealed that group treatment for the service user weighted composite was not significant. Conclusions This study shows how stakeholder values can identify nuances in outcomes depending on the value placed on treatment benefits. Embedding this approach into trial design can strengthen the alignment of outcomes with patient and service priorities and help close the gap between randomized trials and service implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive RemediationDecision Support TechniquesOutcome Assessment, Health CareRandomized Controlled Trials as TopicSchizophreniaStakeholder ParticipationAdultFemaleHumansMaleMiddle Aged

Stichwörter der Autor:innen

clinical trial outcomescognitive remediation therapycomposite outcomesmulti-criteria decision modellingpatient valuesstakeholder values

Autor:innen und Institutionen

  • King's College London, Institute of Psychiatry, Psychology and Neuroscience, Health Service and Population Research, London, SE5 8AF, UK.
  • King's College London, Institute of Psychiatry, Psychology and Neuroscience, Psychology, London, SE5 8AF UK.
  • South London and Maudsley NHS Foundation Trust, London SE5 8AZ, UK.
  • King's College London, Institute of Psychiatry Psychology and Neuroscience, Health Services and Population Research, London, SE5 8AF, UK.
  • King's College London, Institute of Psychiatry Psychology and Neuroscience, Department of Biostatistics and Health Informatics, London SE5 8AF, UK.
  • King's College London, Institute of Psychiatry Psychology and Neuroscience, Department of Biostatistics and Health Informatics, London, SE5 8AF, UK.

ORCID-Profile: Xiaoyu Zhang, Til Wykes, Huajie Jin, Dominic Stringer, Matteo Cella, Alex Kenny, Imogen Kilcoyne, Uzma Zahid, Jonathan Wilson, Rosa Ritunnano, Eileen Joyce

Förderung

  • National Institute for Health and Care Research
  • NIHR Maudsley Biomedical Research Centre
  • NIHR or the Department of Health and Social Care

Zitieren

APA

Zhang, X., Wykes, T., Jin, H., Stringer, D., Pickles, A., Cella, M., Kenny, A., Csipke, E., Kilcoyne, I., Perez, J., Zahid, U., Wilson, J., Birchwood, M., Tinch-Taylor, R., Ritunnano, R., & Joyce, E. (2026). Who Should Decide the Outcome for a Clinical Trial? Comparing the Views of Stakeholders on Intervention Benefit Using Multi-Criteria Decision Modelling of Cognitive Remediation. Schizophrenia Bulletin, 52(3). https://doi.org/10.1093/schbul/sbag006

Vancouver

Zhang X, Wykes T, Jin H, Stringer D, Pickles A, Cella M, et al. Who Should Decide the Outcome for a Clinical Trial? Comparing the Views of Stakeholders on Intervention Benefit Using Multi-Criteria Decision Modelling of Cognitive Remediation. Schizophrenia Bulletin. 2026;52(3). doi:10.1093/schbul/sbag006

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaoyu and Wykes, Til and Jin, Huajie and Stringer, Dominic and Pickles, Andrew and Cella, Matteo and Kenny, Alex and Csipke, Emese and Kilcoyne, Imogen and Perez, Jesus and Zahid, Uzma and Wilson, Jonathan and Birchwood, Max and Tinch-Taylor, Rose and Ritunnano, Rosa and Joyce, Eileen},
  title = {Who Should Decide the Outcome for a Clinical Trial? Comparing the Views of Stakeholders on Intervention Benefit Using Multi-Criteria Decision Modelling of Cognitive Remediation},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  volume = {52},
  number = {3},
  doi = {10.1093/schbul/sbag006}
}
Kostenlos starten →